Elanco To Acquire Bayer’s Animal Health Business for $7.6B

 Elanco To Acquire Bayer’s Animal Health Business for $7.6B

Elanco to Acquire Bayer’s Animal Health Business for $7.6B


  • Elanco acquires Bayer’s animal health business in cash & stock transaction, making a total deal value $7.6B. Bayer to get $5.32B cash as up front and $2.28B/~68M as Elanco’s common share with the expected closure of transaction in mid-2020
  • The focus of the acquisition is to strengthen & accelerating Elanco’s IPP strategy through a pipeline, delivery platforms, scale and access to Bayer R&D, making Elanco second largest animal health leader by revenue across the globe
  • The agreement will double Elanco’s pet business with brands balancing Food Animal/Companion Animal mix and will combine Elanco’s veterinary focus with Bayer’s e-commerceand retail leadership, enhancing the merging market presence thus strengthening the cattle business

Click here to­ read full press release/ article | Ref: Elanco | Image: Display Studios

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post